Health
New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net
Personalized treatment options for patients with lung cancer have come a long way in the past two decades.
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …
-
Noosa News22 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News23 hours agoForum responds to urgent homelessness issues in Nambour
-
Business19 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General16 hours agoMigrants raise concerns over Australia’s English tests for visa applicants